FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Vaxxinity's Free Cash Flow for the
three
months ended in Dec. 2023 was $-12.26 Mil. Vaxxinity's Revenue for the
three
months ended in Dec. 2023 was $0.00 Mil. Therefore, Vaxxinity's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.
The historical rank and industry rank for Vaxxinity's FCF Margin % or its related term are showing as below:
During the past 5 years, the highest FCF Margin % of Vaxxinity was -6353.14%. The lowest was -124709.09%. And the median was -65531.12%.
VAXX's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -139.31 * Ranked among companies with meaningful FCF Margin % only.
Vaxxinity FCF Margin % Historical Data
The historical data trend for Vaxxinity's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Vaxxinity's FCF Margin %
For the Biotechnology subindustry, Vaxxinity's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vaxxinity's FCF Margin % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Vaxxinity's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Vaxxinity's FCF Margin % falls into.
Vaxxinity FCF Margin % Calculation
FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.
Vaxxinity's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vaxxinity FCF Margin % Related Terms
Thank you for viewing the detailed overview of Vaxxinity's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Vaxxinity Inc is engaged in the development and commercialization of prophylactic and therapeutic vaccines to combat chronic disorders and infectious diseases with large patient populations and unmet medical needs. Its pipeline primarily consists of five programs focused on chronic disease, particularly neurodegenerative disorders, in addition to other neurology and cardiovascular indications.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
VAXX has been successfully added to your 